Effectiveness and quality of life in asthmatic patients treated with budesonide/formoterol via Elpenhaler® device in primary care. The “SKIRON” real world study

References

• 2021 GINA Report. Global Strategy for Asthma Management and Prevention. 2021.
   Google Scholar
• Beasley R, Semprini A, Mitchell EA. Risk factors for asthma: is prevention possible? Lancet. 2015;386(9998):1075–1085. doi:10.1016/S0140-6736(15)00156-7.
   PubMed Web of Science ®Google Scholar
• Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I. The MEGA project: a study of the mechanisms involved in the genesis and disease course of asthma. Asthma cohort creation and long-term follow-up. Archivos de Bronconeumologia. 2018;54(7):378–385. doi:10.1016/j.arbres.2017.12.012.
   Web of Science ®Google Scholar
• Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800. doi:10.1016/S0140-6736(17)33311-1.
   PubMed Web of Science ®Google Scholar
• Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H. Determinants and impact of suboptimal asthma control in Europe: the international cross-sectional and longitudinal assessment on asthma control (LIAISON) study. Respir Res. 2016;17(1):51. doi:10.1186/s12931-016-0374-z.
   PubMed Web of Science ®Google Scholar
• Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice. Respir Med. 2009;103(11):1623–1632. doi:10.1016/j.rmed.2009.07.018.
   PubMed Web of Science ®Google Scholar
• Kaitelidou D, Konstantakopoulou O, Siskou O, Tsioni E, Galanis P, Charalambous G, Theodorou M, Sourtzi P, Lemonidou C. Quality of life of asthma patients in Greece: what can we do to improve it? Value Health. 2017;20(9):A648. doi:10.1016/j.jval.2017.08.1504.
   Google Scholar
• Murphy KR, Bender BG. Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence. J Asthma Allergy. 2009;2(July):63–72. doi:10.2147/jaa.s4214.
   PubMedGoogle Scholar
• Barnes PJ. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. BMJ. 2007;335(7618):513. doi:10.1136/bmj.39273.537778.AD.
   PubMedGoogle Scholar
• Ställberg B, Naya I, Ekelund J, Eckerwall G. Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy. Int J Clin Pharmacol Ther. 2015;53(06):447–455. doi:10.5414/CP202224.
   PubMedGoogle Scholar
• Gálffy G, Szilasi M. “Switch to budesonide/formoterol easyhaler inhalation from other inhalers in asthma patients; a real-life study. Airway Pharmacol Treat. 2018:PA1011. doi:10.1183/13993003.congress-2018.PA1011.
   Google Scholar
• Syk J, Vinge I, Sörberg M, Vahteristo M, Rytilä P. A multicenter, observational, prospective study of the effectiveness of switching from budesonide/formoterol turbuhaler to budesonide/formoterol easyhaler. Adv Ther. 2019;36(7):1756–1769. doi:10.1007/s12325-019-00940-7.
   PubMed Web of Science ®Google Scholar
• Gangadi M, Margetaki A, Gavana M, Vantarakis A, Voulgari P, Chlouverakis G, Alamanos I, Rachiotis G, Trypsianis G, Karakosta A, et al. Prevalence of asthma and asthma-like symptoms in Greece: early results of the E.ME. NO study. Epidemiology. 2016:PA4237. doi:10.1183/13993003.congress-2016.PA4237.
   Google Scholar
• Juniper EF, Svensson K, Mörk A-C, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553–558. doi:10.1016/j.rmed.2004.10.008.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.012.
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt G, Ferrie P, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–907. doi:10.1034/j.1399-3003.1999.14d29.x.
   PubMed Web of Science ®Google Scholar
• Juniper E. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47(1):81–87. doi:10.1016/0895-4356(94)90036-1.
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use? Respir Med. 2001;95(5):319–323. doi:10.1053/rmed.2001.1034.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the mini asthma quality of life questionnaire. Eur Respir J. 1999;14(1):32–38. doi:10.1034/j.1399-3003.1999.14a08.x.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76–83. doi:10.1136/thx.47.2.76.
   PubMed Web of Science ®Google Scholar
• Juniper EF. Health-related quality of life in asthma. Curr Opin Pulm Med. 1999;5(2):105–110.
   PubMedGoogle Scholar
• Bouros D, Evangeliou MN. Critical steps: a non-interventional, multicenter, prospective, observational study on critical handling errors with DPI use, in asthma and COPD patients. J Pulm Respir Med. 2016;6(4) doi:10.4172/2161-105X.1000360.
   Google Scholar
• Zervas E, Samitas K, Gaga M. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. Int J Chron Obstructive Pulm Dis. 2016;11(August):1845–1855. doi:10.2147/COPD.S113870.
   PubMedGoogle Scholar
• Bakakos P, Papakosta D, Loukides S. Budesonide/formoterol via the Elpenhaler® device in asthmatic patients: a real-world effectiveness study (The BOREAS study). Pneumon. 2021:1–10. doi:10.18332/pne/144485.
   Web of Science ®Google Scholar
• Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi:10.1164/rccm.201804-0682CI.
   PubMed Web of Science ®Google Scholar
• Katsoulis K. Diagnostic approaches in asthma. www.pneumon.org. 2014;1(1):74.
   Google Scholar
• Sciberras N, Gouder C, Montefort S. COVID-19 in severe asthma treated with omalizumab: the Maltese perspective. Pneumon. 2021;34(3):11. https://scholar.archive.org/work/vbhqz6uckzbkdmcumehljq6h64/access/wayback/http://www.pneumon.org/pdf-141591-68384?filename=COVID_19+in+severe+asthma.pdf.
   Web of Science ®Google Scholar
• Kocks JWH, Chrystyn H, van der Palen J, Thomas M, Yates L, Landis SH, Driessen MT, Gokhale M, Sharma R, Molimard M. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Primary Care Respir Med. 2018;28(1):43. doi:10.1038/s41533-018-0110-x.
   PubMed Web of Science ®Google Scholar
• Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen R. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19(1):10. doi:10.1186/s12931-017-0710-y.
   PubMed Web of Science ®Google Scholar
• Karampitsakos T, Hillas G, Zervas E, Bakakos P, Stratakos G, Dimakou K, Manali E, Bouros D, Papiris S, Tzouvelekis A, et al. Prospective evaluation for inhalation devices in Greek patients with COPD and asthma: the PAIR study. Pulm Pharmacol Ther. 2020;60:101882. doi:10.1016/j.pupt.2019.101882.
   PubMed Web of Science ®Google Scholar
• Palen J v d, Palen J v d, van der Valk P, Goosens M, Groothuis-Oudshoorn K, Brusse-Keizer M. A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease. Exp Opin Drug Deliv. 2013;10(9):1171–1178. doi:10.1517/17425247.2013.817387.
   PubMed Web of Science ®Google Scholar
• Maricoto T, Vaz Rodrigues L, Teixeira G, Valente C, Andrade L, Saraiva A. Assessment of inhalation technique in clinical and functional control of asthma and chronic obstructive pulmonary disease. Acta Med Portuguesa. 2015;28(6):702–707. doi:10.20344/amp.5905.
   PubMed Web of Science ®Google Scholar
• Plaza V, Giner J, Curto E, Alonso-Ortiz MB, Orue MI, Vega JM, Cosío BG, Linares VB, Mora RB, Cesar EC, et al. Determinants and differences in satisfaction with the inhaler among patients with asthma or COPD. J Allergy Clin Immunol Pract. 2020;8(2):645–653. doi:10.1016/j.jaip.2019.09.020.
   PubMed Web of Science ®Google Scholar
• Yildiz F. and Asthma Inhaler Treatment Study Group. Importance of inhaler device use status in the control of asthma in adults: the asthma inhaler treatment study. Respir Care. 2014;59(2):223–230. doi:10.4187/respcare.02478.
   PubMed Web of Science ®Google Scholar
• Kostikas K. Real-life effectiveness of ICS/LABA inhalers in asthma: the evidence generated and future needs for optimal patient management. Pneumon. 2021;34(4):1–3. doi:10.18332/pne/144496.
   Web of Science ®Google Scholar
• Kourlaba G, Bakakos P, Loukides S, Vellopoulou K, Solakidi A, Maniadakis N. The self-reported prevalence and disease burden of asthma in Greece. J Asthma. 2019;56(5):478–497. doi:10.1080/02770903.2018.1471704.
   PubMed Web of Science ®Google Scholar
• Livadiotis C, Lambrinou E, Raftopoulos V, Middleton N. Evaluation of the psychometric properties of the Greek version of the active life with asthma (Gr-ALMA) review: a descriptive methodological study. BMC Health Serv Res. 2019;19(1):322. doi:10.1186/s12913-019-4155-5.
   PubMedGoogle Scholar
• Sadatsafavi M, McTaggart-Cowan H, Chen W, FitzGerald JM. Quality of life and asthma symptom control: room for improvement in care and measurement. Value Health. 2015;18(8):1043–1049. doi:10.1016/j.jval.2015.07.008.
   PubMed Web of Science ®Google Scholar
• Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007;120(2):396–402. doi:10.1016/j.jaci.2007.04.040.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Barnes NC, Greening AP, Jones PW, Pedersen S. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax. 2010;65(8):747–752. doi:10.1136/thx.2009.128504.
   PubMed Web of Science ®Google Scholar
• Sears MR, Radner F. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. Respir Med. 2009;103(12):1960–68. doi:10.1016/j.rmed.2009.08.007.
   PubMed Web of Science ®Google Scholar